Detalhe da pesquisa
1.
Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: results of a randomized, double-blind phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving chemotherapy.
BMC Cancer
; 19(1): 122, 2019 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30727980
2.
Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy: A Prespecified Analysis of the monarchE Randomized Clinical Trial.
JAMA Oncol
; 8(8): 1190-1194, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35653145